Cargando…
In vivo stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemia
Asparagine is a non-essential amino acid since it can either be taken up via the diet or synthesized by asparagine synthetase. Acute lymphoblastic leukemia (ALL) cells do not express asparagine synthetase or express it only minimally, which makes them completely dependent on extracellular asparagine...
Autores principales: | Van Trimpont, Maaike, Schalk, Amanda M., De Visser, Yanti, Nguyen, Hien Anh, Reunes, Lindy, Vandemeulebroecke, Katrien, Peeters, Evelien, Su, Ying, Lee, Hyun, Lorenzi, Philip L., Chan, Wai-Kin, Mondelaers, Veerle, De Moerloose, Barbara, Lammens, Tim, Goossens, Steven, Van Vlierberghe, Pieter, Lavie, Arnon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890011/ https://www.ncbi.nlm.nih.gov/pubmed/35979719 http://dx.doi.org/10.3324/haematol.2022.281390 |
Ejemplares similares
-
Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy
por: Van Trimpont, Maaike, et al.
Publicado: (2022) -
P320: A NOVEL MAMMALIAN L-ASPARAGINASE WITH NO L-GLUTAMINASE ACTIVITY IS HIGHLY EFFICACIOUS AGAINST T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN VIVO
por: Van Trimpont, Maaike, et al.
Publicado: (2023) -
CLL-033 Is COVID-19 Infection a Trigger for Progression of CLL?
por: Popov, Viola, et al.
Publicado: (2022) -
CLL-050 Induction of Neutralizing Antibodies in Chronic Lymphocytic Leukemia Patients After SARS-CoV-2 mRNA Vaccination: A Monocentric Experience
por: Mavilia, Fabrizio, et al.
Publicado: (2022) -
CLL-224 Coronavirus Disease Mortality and Outcome in Macedonian Patients With Chronic Lymphocytic Leukemia: Single-Center Experience
por: Trajkova, Sanja, et al.
Publicado: (2022)